GI Billing — Scope Procedures, Maximized Revenue

Proven Results

• 31% Average Revenue Increase
• 95.3% First-Pass Claim Rate
• 43% Reduction in Denials
• 14.5 Days Faster Payment Collection

Common Billing Challenges

Complex Endoscopy Coding

Endoscopic procedures require precise CPT coding with multiple modifiers for polyp removal, biopsies, and therapeutic interventions.

Procedure Bundling Issues

Multiple GI procedures performed during the same session often face bundling challenges and modifier requirements.

Prior Authorization Delays

Advanced endoscopic procedures and diagnostic tests require extensive prior authorizations causing treatment delays.

ASC vs Office Setting Billing

Different reimbursement rates and coding requirements for procedures performed in ASC versus office settings.

Pathology Coordination

Managing biopsy specimens and coordinating pathology billing for tissue samples collected during procedures.

Screening vs Diagnostic Coding

Critical distinction between screening and diagnostic colonoscopies affects coverage and patient responsibility.

Our Solutions

GI-Certified Coding Experts

Our team includes specialized coders with extensive training in gastroenterology procedures and CPT coding.

• Accurate endoscopy and colonoscopy coding
• Expertise in therapeutic procedure modifiers
• Knowledge of polyp removal and biopsy coding
• Reduced coding errors and denials

Procedure Optimization

Maximize reimbursements through proper bundling management and modifier application for multiple procedures.

• Optimized bundling and unbundling strategies
• Correct modifier usage for multiple procedures
• Higher reimbursement per procedure session
• Reduced payer audit risks

Endoscopy Suite Revenue Capture

Ensure every billable element of colonoscopies, EGDs, and endoscopic procedures is correctly coded and submitted.

• Correct polyp removal technique coding (hot biopsy vs. snare vs. cold forceps)
• Proper screening-to-diagnostic colonoscopy conversion billing
• Anesthesia service coordination for complex endoscopy cases
• Same-day procedure bundling compliance for multi-procedure sessions

Real-Time Authorization Management

Dedicated team handles all prior authorization requirements for GI procedures and diagnostic tests.

• Faster approval times for procedures
• Reduced administrative burden
• Higher approval rates
• Streamlined scheduling process

Specialized Services

Colonoscopy Billing

Expert billing for screening and diagnostic colonoscopies with proper screening-to-diagnostic conversion.

• Screening colonoscopy coding
• Diagnostic procedure billing
• Polyp removal coding
• High-risk screening management

Upper Endoscopy (EGD)

Specialized billing for upper GI endoscopy procedures including biopsies and therapeutic interventions.

• EGD procedure coding
• Biopsy billing
• Dilation procedures
• Foreign body removal

Advanced Procedures

Complex billing for ERCP, EUS, and other advanced endoscopic procedures.

• ERCP billing
• Endoscopic ultrasound
• Capsule endoscopy
• Advanced therapeutic procedures

GI Lab Services

Comprehensive billing for in-office and ASC-based GI lab services and diagnostics.

• Facility fee billing
• Anesthesia coordination
• Pathology management
• Multi-location support

Common CPT Codes Reference

Key codes include 45378 (Colonoscopy, diagnostic, with or without collection of speci), 45380 (Colonoscopy with biopsy, single or multiple), 45385 (Colonoscopy with removal of tumor(s), polyp(s), by snare tec), 45381 (Colonoscopy with directed submucosal injection(s)), 43239 (Esophagogastroduodenoscopy (EGD) with biopsy), 43251 (EGD with removal of tumor(s), polyp(s) by snare technique), 43270 (EGD with ablation of tumor(s), polyp(s), or other lesion(s)), 96365 (IV infusion, initial, up to 1 hour, for therapy/prophylaxis/), 96366 (IV infusion, each additional hour (add-on)), 43460 (Esophagogastric tamponade with balloon). Proper code selection requires understanding of bundling rules, NCCI edits, and modifier usage.

Expert Billing Insights

Colonoscopy Coding: Screening vs. Diagnostic and Incidental Polyp Rules

The distinction between screening and diagnostic colonoscopy is one of the most important — and frequently miscoded — areas in GI billing. A screening colonoscopy (Z12.11) should be billed differently than a diagnostic colonoscopy (K92.1, K57.30, etc.), particularly for Medicare patients. When polyps are found during a screening colonoscopy, the procedure upgrades to a therapeutic code (45385, 45380), but the preventive service cost-sharing still applies under certain conditions. Incorrect coding of screening versus diagnostic colonoscopy affects patient cost-sharing significantly.

• Medicare screening colonoscopy: bill G0121 for average risk, G0105 for high risk
• When a polyp is found during a screening: G0121 converts to 45385 but waived cost-share may still apply
• ACA requires waived cost-sharing for preventive colonoscopies — but only if no polyp is found under some plans
• Document indication clearly: family history, prior polyps, or symptoms determines screening vs. diagnostic

GI Infusion Therapy Billing: Biologics and Site-of-Service Optimization

Biologic infusion therapy for IBD (Crohn's, ulcerative colitis) represents one of the highest-revenue opportunities in gastroenterology. Medications like infliximab (Remicade), vedolizumab (Entyvio), and ustekinumab (Stelara) are billed using HCPCS J-codes at drug-specific rates. The site of service dramatically affects reimbursement — hospital outpatient infusion reimburses significantly more than physician office infusion for the same drug under Medicare, while commercial payers often favor physician office or home infusion. Understanding site-of-service optimization is critical.

• Infliximab: J1745; vedolizumab: J3380; ustekinumab: J3358 — verify per HCPCS update
• Bill actual dose administered; document vial wastage for single-dose vials
• Site of service: 22 (outpatient hospital) vs. 11 (physician office) affects Medicare payment
• Prior authorization for all biologics — submit clinical documentation proactively

ERCP and Complex Endoscopy Billing: Modifiers and Documentation

Endoscopic Retrograde Cholangiopancreatography (ERCP) is one of the most complex GI procedures to bill correctly. ERCP codes are hierarchical — more complex codes include all services in less complex codes. Performing multiple interventions during one ERCP session does not necessarily mean billing multiple codes. The interventions performed (sphincterotomy, stone extraction, stent placement) each have specific add-on and stand-alone codes. Detailed operative documentation is the foundation of defensible ERCP billing.

• ERCP with sphincterotomy (43262) includes diagnostic ERCP (43260) — do not bill both
• Stone extraction (43264) and stent placement (43267) are each separately billable with ERCP
• Document fluoroscopy time, contrast used, and all therapeutic interventions performed
• Modifier 52 for reduced services when ERCP cannot be completed due to anatomy or patient tolerance

Payer-Specific Billing Tips

Medicare

• Medicare covers screening colonoscopy every 10 years (average risk) or 2 years (high risk)
• G0105 (high-risk screening) vs. G0121 (average-risk) — correct code affects patient cost-share
• Anesthesia for GI endoscopy: propofol by CRNA/anesthesiologist billed separately
• Biologic infusions under Medicare Part B: physician office or outpatient setting required

Medicaid

• Colonoscopy screening coverage varies by state Medicaid plan — verify member benefits
• Biologic therapy for IBD requires prior authorization and often step therapy through cheaper biologics
• ERCP prior authorization requirements differ by state managed Medicaid plan
• FQHCs and RHCs providing GI services bill at enhanced encounter rates

Commercial Payers

• ACA preventive colonoscopy requires zero cost-share — incidental polyp removal may create cost-share
• Commercial biologic prior auth: step therapy (5-ASA, immunomodulators) may be required first
• ERCP referrals: ensure provider is in-network for facility and professional components separately
• GI-specific benefit verification: confirm endoscopy benefits, prior auth requirements, and anesthesia coverage

Biologic Drug Prior Authorization

• All biologic prior authorizations require IBD diagnosis confirmation (endoscopic or histologic)
• Submit CDAI/Mayo scores and prior therapy failures to support initial biologic auth
• Annual reauthorization typically requires documented clinical response or remission maintenance
• Biosimilars may be required by payers before brand biologics are authorized

Related Billing Resources

• Hepatology & Liver Billing
• Oncology Billing
• Pathology & Lab Billing
• Medical Coding Services
• Prior Authorization Services
• CPT Codes Reference Guide
• ICD-10 Codes Reference

Key Services

• gastroenterology billing
• GI billing
• endoscopy billing
• colonoscopy billing
• gastrointestinal billing
• digestive health billing